SEC Filing Summary: India Globalization Capital, Inc. (IGC Pharma, Inc.)
Business Context and Reporting Period
This Form 8-K Current Report was filed on April 11, 2018, by India Globalization Capital, Inc. (also referenced as IGC Pharma, Inc.). The report discloses a corporate governance event regarding the appointment of a new independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the change in the registrant's certifying accountant and does not contain financial statement data.
Material Changes
- Change in Auditor: On April 11, 2018, the Audit Committee approved the appointment of Manohar Chowdhry & Associates ("MCA") as the new independent registered public accounting firm.
- Scope of Appointment: MCA will serve for the fiscal years ending March 31, 2018, and March 31, 2019.
- Consultation History: The company confirmed no prior consultations with MCA regarding accounting principles, audit opinions, or disagreements during the two most recent fiscal years.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management outlook, or specific risk factors beyond the standard disclosure of the auditor change. The appointment of MCA is subject to ratification by stockholders at the 2018 Annual Meeting of Stockholders. MCA is a PCAOB-registered firm based in India with 12 offices and approximately 350 employees.
Investor Verification Checklist
- Verify the outcome of the stockholder ratification for Manohar Chowdhry & Associates at the 2018 Annual Meeting.
- Review the letter from Manohar Chowdhry & Associates (Exhibit 16.1) for any additional disclosures regarding the change.
- Confirm the identity of the previous independent accounting firm to understand the context of the transition.
- Check subsequent filings for the first financial statements audited by the new firm.